Evidence map

SynthesisDiabetes, obesity & metabolism2017

Efficacy and safety of lixisenatide in patients with type 2 diabetes and renal impairment.

Markolf Hanefeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 28449324